Literature DB >> 12510018

Coronary atherosclerosis and somatic mutations: an overview of the contributive factors for oxidative DNA damage.

Maria Grazia Andreassi1.   

Abstract

Coronary artery disease (CAD) is a multifactorial process that appears to be caused by the interaction of environmental risk factors with multiple predisposing genes. Genetic research on CAD has traditionally focused on investigation aimed at identifying disease-susceptibility genes. Recent evidence suggests that somatically acquired DNA mutations may also contribute significantly to the pathogenesis of the disease, underlining the similarity between atherosclerotic and carcinogenic processes. The generation of oxidative stress has been emphasized as an important cause of DNA damage in atherosclerosis. This review highlights some of the major atherogenic risk factors as likely mediators in the oxidative modification of DNA. It also examines the hypothesis that an increase in oxidative stress may derive from "oxidatively" damaged mitochondria. Accordingly, further research in this field should be given high priority, since increased somatic DNA damage could be an important pathogenic factor and an additional prognostic predictor, as well as a potential target for therapeutic strategies in coronary artery disease. Copyright 2002 Elsevier Science B.V.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12510018     DOI: 10.1016/s1383-5742(02)00089-3

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  36 in total

1.  DNA repair XRCC1 Arg399Gln polymorphism is associated with the risk of development of end-stage renal disease.

Authors:  Sinan Trabulus; Gulgun S Guven; Mehmet R Altiparmak; Bahadir Batar; Ozlem Tun; Ayse S Yalin; Aydin Tunckale; Mehmet Guven
Journal:  Mol Biol Rep       Date:  2012-06       Impact factor: 2.316

2.  Keap1 is a redox-regulated substrate adaptor protein for a Cul3-dependent ubiquitin ligase complex.

Authors:  Donna D Zhang; Shih-Ching Lo; Janet V Cross; Dennis J Templeton; Mark Hannink
Journal:  Mol Cell Biol       Date:  2004-12       Impact factor: 4.272

3.  Genomic rearrangements on VCAM1, SELE, APEG1and AIF1 loci in atherosclerosis.

Authors:  D A Arvanitis; G A Flouris; D A Spandidos
Journal:  J Cell Mol Med       Date:  2005 Jan-Mar       Impact factor: 5.310

Review 4.  A high-fidelity method for genomic sequencing of single somatic cells reveals a very high mutational burden.

Authors:  Jan Vijg; Xiao Dong; Lei Zhang
Journal:  Exp Biol Med (Maywood)       Date:  2017-07

5.  Assessment of oxidative, inflammatory, and fibrinolytic biomarkers and DNA strand breakage in hypercholesterolemia.

Authors:  Renata da Silva Pereira; Etiane Tatsch; Guilherme Vargas Bochi; Helena Kober; Thiago Duarte; Greice Franciele Feyh dos Santos Montagner; José Edson Paz da Silva; Marta Maria Medeiros Frescura Duarte; Ivana Beatrice Mânica da Cruz; Rafael Noal Moresco
Journal:  Inflammation       Date:  2013-08       Impact factor: 4.092

Review 6.  DNA damage, vascular senescence and atherosclerosis.

Authors:  Maria Grazia Andreassi
Journal:  J Mol Med (Berl)       Date:  2008-06-19       Impact factor: 4.599

7.  Ectodermal-neural cortex 1 down-regulates Nrf2 at the translational level.

Authors:  Xiao-Jun Wang; Donna D Zhang
Journal:  PLoS One       Date:  2009-05-08       Impact factor: 3.240

Review 8.  Ionizing radiation and aging: rejuvenating an old idea.

Authors:  Richard B Richardson
Journal:  Aging (Albany NY)       Date:  2009-11-17       Impact factor: 5.682

9.  Susceptibility to Oxidative Stress is Greater in Korean Patients with Coronary Artery Disease than Healthy Subjects.

Authors:  Eunju Park; Yoo Kyoung Park; Sang-Mi Kim; Hye-Jin Lee; Myung-Hee Kang
Journal:  J Clin Biochem Nutr       Date:  2009-10-28       Impact factor: 3.114

10.  Effects of Satureja khuzestanica on Serum Glucose, Lipids and Markers of Oxidative Stress in Patients with Type 2 Diabetes Mellitus: A Double-Blind Randomized Controlled Trial.

Authors:  Sanaz Vosough-Ghanbari; Roja Rahimi; Shabnam Kharabaf; Shima Zeinali; Azadeh Mohammadirad; Somayeh Amini; Nargues Yasa; Alinazar Salehnia; Tayebeh Toliat; Shekoufeh Nikfar; Bagher Larijani; Mohammad Abdollahi
Journal:  Evid Based Complement Alternat Med       Date:  2008-02-27       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.